Transcriptomics

Dataset Information

0

RPL22 is a tumor suppressor in MSI-high cancers and a key splicing regulator of MDM4


ABSTRACT: Microsatellite instability high (MSI-H) tumors are malignant tumors that, despite harboring a high mutational burden, often have intact TP53. One of the most frequent mutations in MSI-H tumors is a frameshift mutation in RPL22, a ribosomal protein. Here, we identified RPL22 as a modulator of MDM4 splicing through an alternative splicing switch in exon 6. RPL22 loss increased MDM4 exon 6 inclusion, cell proliferation, and augmented resistance to the MDM inhibitor Nutlin-3A. RPL22 represses expression of its paralog, RPL22L1, by mediating the splicing of a cryptic exon corresponding to a truncated transcript. Therefore, RPL22 loss is a driver of oncogenic MDM4 induction and key to a common splicing circuit in MSI-H tumors that may inform therapeutic targeting of the MDM4-p53 axis and oncogenic RPL22L1 induction.

ORGANISM(S): Homo sapiens

PROVIDER: GSE263237 | GEO | 2024/07/22

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA1096328 | ENA
2025-05-13 | GSE267500 | GEO
2024-10-11 | GSE245356 | GEO
2025-05-13 | GSE267503 | GEO
2024-09-13 | GSE276681 | GEO
| S-EPMC10723389 | biostudies-literature
| PRJNA1016372 | ENA
| PRJNA1111739 | ENA
| 2266966 | ecrin-mdr-crc
| PRJEB53321 | ENA